Patents by Inventor Colin Stephen Cooper

Colin Stephen Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230349000
    Abstract: The present invention relates to the classification of cancers, in particular prostate cancers, using samples from patients. In particular, the invention provides methods for identifying potentially aggressive prostate cancers to determine which cancers are or will become aggressive (and hence require treatment) and which will remain indolent (and will therefore not require treatment). The present invention is therefore useful to identify patients with a poor prognosis. The specific population of cancer identified by the present invention is referred to herein as DESNT cancer. The invention also provides biomarker panels useful in the diagnosis and prognosis of cancer.
    Type: Application
    Filed: July 5, 2023
    Publication date: November 2, 2023
    Inventors: Bogdan-Alexandru Luca, Vincent Moultion, Daniel Simon Brewer, Colin Stephen Cooper
  • Patent number: 11746380
    Abstract: The present invention relates to the classification of cancers, in particular prostate cancers, using samples from patients. In particular, the invention provides methods for identifying potentially aggressive prostate cancers to determine which cancers are or will become aggressive (and hence require treatment) and which will remain indolent (and will therefore not require treatment). The present invention is therefore useful to identify patients with a poor prognosis. The specific population of cancer identified by the present invention is referred to herein as DESNT cancer. The invention also provides biomarker panels useful in the diagnosis and prognosis of cancer.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: September 5, 2023
    Assignee: UNIVERSITY OF EAST ANGLIA
    Inventors: Bogdan-Alexandru Luca, Vincent Moultion, Daniel Simon Brewer, Colin Stephen Cooper
  • Publication number: 20220093251
    Abstract: The present invention relates to biomarkers and diagnostic profiles based on the expression status of particular genes for use in the diagnosis of prostate cancer, in particular the early detection of prostate cancer and prediction of disease progression and Gleason ?4 cancer. The present invention also provides methods of diagnosis and treatment of prostate cancer, and kits for the early detection of prostate cancer based on the expression status of the biomarkers in biological samples, in particular urine samples.
    Type: Application
    Filed: January 28, 2020
    Publication date: March 24, 2022
    Inventors: Colin Stephen Cooper, Jeremy Paul Clark, Daniel Simon Brewer, Shea Peter Connell, Helen Marie Curley
  • Publication number: 20200263255
    Abstract: The present invention relates to the classification of cancers, in particular prostate cancers, using samples from patients. In particular, the invention provides methods for identifying potentially aggressive prostate cancers to determine which cancers are or will become aggressive (and hence require treatment) and which will remain indolent (and will therefore not require treatment). The present invention is therefore useful to identify patients with a poor prognosis. The specific population of cancer identified by the present invention is referred to herein as DESNT cancer. The invention also provides biomarker panels useful in the diagnosis and prognosis of cancer.
    Type: Application
    Filed: October 5, 2017
    Publication date: August 20, 2020
    Inventors: Bogdan-Alexandru Luca, Vincent Moultion, Daniel Simon Brewer, Colin Stephen Cooper